Pesquisar
Revvity Inc
RVTYAdicionar à lista de desejos
101.000USD
+2.150+2.17%
Fechamento 05/08, 16:00（ET）Cotações atrasadas em 15 min
11.29BValor de mercado
48.51P/L TTM
Mais detalhes de Revvity Inc Empresa
Revvity, Inc. is a provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. The Company has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.
Informações de Revvity Inc
Código da empresaRVTY
Nome da EmpresaRevvity Inc
Data de listagemAug 12, 2101
CEOSingh (Prahlad R)
Número de funcionários11000
Tipo de títulosOrdinary Share
Fim do ano fiscalAug 12
Endereço77 4Th Avenue
CidadeWALTHAM
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal02451
Telefone17816636900
Sitehttps://www.revvity.com/
Código da empresaRVTY
Data de listagemAug 12, 2101
CEOSingh (Prahlad R)
Executivos da empresa Revvity Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Prahlad R. Singh, Ph.D.
Dr. Prahlad R. Singh, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
113.31K
+14.54%
Mr. Alexandros P. (Alexis) Michas
Mr. Alexandros P. (Alexis) Michas
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
61.08K
+25.61%
Mr. Joel S. Goldberg
Mr. Joel S. Goldberg
Senior Vice President - Administration, General Counsel, Secretary
Senior Vice President - Administration, General Counsel, Secretary
41.51K
+9.21%
Dr. Peter Barrett, Ph.D.
Dr. Peter Barrett, Ph.D.
Independent Director
Independent Director
26.01K
--
Ms. Miriame Victor
Ms. Miriame Victor
Chief Commercial Officer, Senior Vice President
Chief Commercial Officer, Senior Vice President
18.12K
+21.16%
Mr. Maxwell Krakowiak
Mr. Maxwell Krakowiak
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
16.41K
-38.94%
Mr. Tajinder S. Vohra
Mr. Tajinder S. Vohra
Senior Vice President - Global Operations
Senior Vice President - Global Operations
13.96K
+25.23%
Ms. Pascale Witz
Ms. Pascale Witz
Independent Director
Independent Director
13.71K
--
Mrs. Anita Gonzales
Mrs. Anita Gonzales
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
7.32K
-1.09%
Mr. Michael A. Klobuchar
Mr. Michael A. Klobuchar
Independent Director
Independent Director
5.09K
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Prahlad R. Singh, Ph.D.
Dr. Prahlad R. Singh, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
113.31K
+14.54%
Mr. Alexandros P. (Alexis) Michas
Mr. Alexandros P. (Alexis) Michas
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
61.08K
+25.61%
Mr. Joel S. Goldberg
Mr. Joel S. Goldberg
Senior Vice President - Administration, General Counsel, Secretary
Senior Vice President - Administration, General Counsel, Secretary
41.51K
+9.21%
Dr. Peter Barrett, Ph.D.
Dr. Peter Barrett, Ph.D.
Independent Director
Independent Director
26.01K
--
Ms. Miriame Victor
Ms. Miriame Victor
Chief Commercial Officer, Senior Vice President
Chief Commercial Officer, Senior Vice President
18.12K
+21.16%
Mr. Maxwell Krakowiak
Mr. Maxwell Krakowiak
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
16.41K
-38.94%
Detalhamento da receita
Moeda: USDAtualizado em: seg, 6 de abr
Moeda: USDAtualizado em: seg, 6 de abr
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
FY2018
Os dados relevantes ainda não foram divulgados pela empresa.
Por RegiãoUSD
Nome
Receita
Proporção
Americas
1.26B
43.98%
United States
1.13B
39.43%
Other Foreign
1.00B
35.02%
Europe
824.98M
28.89%
Asia
775.11M
27.14%
Outro
-2.13B
-74.46%
Por Empresa
Por Região
Os dados relevantes ainda não foram divulgados pela empresa.
Distribuição de ações
Atualizado em: dom, 10 de mai
Atualizado em: dom, 10 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
T. Rowe Price Investment Management, Inc.
20.08%
EdgePoint Investment Group Inc.
7.63%
T. Rowe Price Associates, Inc.
7.54%
Janus Henderson Investors
7.30%
Vanguard Capital Management, LLC
6.56%
Outro
50.89%
Investidores
Investidores
Proporção
T. Rowe Price Investment Management, Inc.
20.08%
EdgePoint Investment Group Inc.
7.63%
T. Rowe Price Associates, Inc.
7.54%
Janus Henderson Investors
7.30%
Vanguard Capital Management, LLC
6.56%
Outro
50.89%
Tipos de investidores
Investidores
Proporção
Investment Advisor
78.85%
Investment Advisor/Hedge Fund
27.27%
Hedge Fund
4.07%
Research Firm
2.65%
Pension Fund
1.22%
Sovereign Wealth Fund
0.74%
Bank and Trust
0.68%
Individual Investor
0.34%
Family Office
0.05%
Participação acionária institucional
Atualizado em: dom, 5 de abr
Atualizado em: dom, 5 de abr
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2026Q1
1187
116.42M
104.13%
-12.22M
2025Q4
1177
117.55M
103.68%
-9.50M
2025Q3
1177
117.06M
100.85%
-8.83M
2025Q2
1199
113.79M
98.03%
-7.04M
2025Q1
1255
117.73M
99.83%
-3.82M
2024Q4
1277
114.54M
95.28%
-3.97M
2024Q3
1253
112.35M
91.11%
-5.77M
2024Q2
1249
112.44M
91.13%
-1.63M
2024Q1
1287
107.57M
87.09%
-8.24M
2023Q4
1315
109.29M
88.55%
-2.41M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
T. Rowe Price Investment Management, Inc.
22.45M
20.08%
-54.14K
-0.24%
Dec 31, 2025
EdgePoint Investment Group Inc.
8.54M
7.63%
-38.62K
-0.45%
Dec 31, 2025
T. Rowe Price Associates, Inc.
8.43M
7.54%
+436.81K
+5.46%
Dec 31, 2025
Janus Henderson Investors
8.16M
7.3%
+533.91K
+7.00%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
5.64M
5.04%
-400.11K
-6.63%
Dec 31, 2025
State Street Investment Management (US)
4.31M
3.86%
-635.64K
-12.85%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
2.61M
2.34%
+486.16K
+22.87%
Dec 31, 2025
Geode Capital Management, L.L.C.
2.89M
2.59%
-66.89K
-2.26%
Dec 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
First Trust Indxx Medical Devices ETF
2.12%
Invesco S&P 500 Equal Weight Health Care ETF
1.85%
T Rowe Price Capital Appreciation Equity ETF
1.36%
Simplify Health Care ETF
1.29%
ROBO Global Healthcare Technology & Innovation ETF
1.16%
First Trust Health Care Alphadex Fund
0.93%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
0.84%
VanEck Morningstar SMID Moat ETF
0.64%
Neuberger Berman Small-Mid Cap ETF
0.56%
NYLI Candriam US Mid Cap Equity ETF
0.5%
Ver Mais
First Trust Indxx Medical Devices ETF
Proporção2.12%
Invesco S&P 500 Equal Weight Health Care ETF
Proporção1.85%
T Rowe Price Capital Appreciation Equity ETF
Proporção1.36%
Simplify Health Care ETF
Proporção1.29%
ROBO Global Healthcare Technology & Innovation ETF
Proporção1.16%
First Trust Health Care Alphadex Fund
Proporção0.93%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
Proporção0.84%
VanEck Morningstar SMID Moat ETF
Proporção0.64%
Neuberger Berman Small-Mid Cap ETF
Proporção0.56%
NYLI Candriam US Mid Cap Equity ETF
Proporção0.5%
Dividendo
Um total de
137.14M
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Apr 30, 2026
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Aug 07, 2026 going ex on Jul 17, 2026
Jul 17, 2026
Aug 07, 2026
Jul 17, 2026
Jan 26, 2026
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on May 08, 2026 going ex on Apr 17, 2026
Apr 17, 2026
May 08, 2026
Apr 17, 2026
Oct 23, 2025
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Feb 06, 2026 going ex on Jan 16, 2026
Jan 16, 2026
Feb 06, 2026
Jan 16, 2026
Jul 24, 2025
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Nov 07, 2025 going ex on Oct 17, 2025
Oct 17, 2025
Nov 07, 2025
Oct 17, 2025
Apr 24, 2025
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Aug 08, 2025 going ex on Jul 18, 2025
Jul 18, 2025
Aug 08, 2025
Jul 18, 2025
Jan 23, 2025
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on May 09, 2025 going ex on Apr 17, 2025
Apr 18, 2025
May 09, 2025
Apr 17, 2025
Oct 24, 2024
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Feb 07, 2025 going ex on Jan 17, 2025
Jan 17, 2025
Feb 07, 2025
Jan 17, 2025
Jul 25, 2024
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Nov 08, 2024 going ex on Oct 18, 2024
Oct 18, 2024
Nov 08, 2024
Oct 18, 2024
Apr 25, 2024
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Aug 09, 2024 going ex on Jul 19, 2024
Jul 19, 2024
Aug 09, 2024
Jul 19, 2024
Jan 25, 2024
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on May 10, 2024 going ex on Apr 18, 2024
Apr 19, 2024
May 10, 2024
Apr 18, 2024
Ver Mais
Desdobramento de ações
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
